Awad, Wedad B.
Nazer, Lama
Elfarr, Salam
Abdullah, Maha
Hawari, Feras
Article History
Received: 10 February 2021
Accepted: 1 June 2021
First Online: 16 June 2021
Declarations
:
: The study protocol was approved by the Institutional Review Board of King Hussein Cancer Center under the reference number of 20KHCC109, and the Institutional Review Board granted the waiver for the informed consent, the permission to access the raw data and patients’ electronic medical records. The data were coded and anonymized before analysis. The study followed the relevant guidelines and regulations of both good clinical practice guidelines and our Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.